The trademark SAMBULIN was filed by DIAGNOSIS S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on October 6, 2014, and received one opposition filed on January 6, 2015 by Novartis AG on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 6, 2015
The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on February 7, 2024.
Change of name and address of the trademark registration was recorded on November 5, 2015. Change of name and address of the trademark registration was recorded on December 1, 2019.